TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

MELINTA

Infectious DiseaseDermatology
Pharma

MELINTA is a pharmaceutical company focused on Infectious Disease, Dermatology. Key products include BAXDELA.

2017
Since
1
Drugs
-
Trials
0
Approved (2yr)

Key Drugs

BAXDELA
delafloxacin meglumine
2 indications · 2017

Recent Activity

No recent activity
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 74%
1 drugs Phase 3: 2 Phase 2: 4 Phase 1: 3
Dermatology 26%
1 drugs Phase 2: 1 Phase 1: 1

Pipeline Strength Pro

Loading...

Competitors Pro

Pfizer big-pharma
Infectious Disease, Dermatology
Baxter specialty
Infectious Disease, Dermatology
B BRAUN specialty
Infectious Disease, Dermatology
COSETTE other
Dermatology, Infectious Disease
BAUSCH AND LOMB specialty
Infectious Disease, Dermatology